400 related articles for article (PubMed ID: 12740389)
1. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
Lee PS; Chang C; Liu D; Derynck R
J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
[TBL] [Abstract][Full Text] [Related]
2. Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4.
Lin X; Liang M; Liang YY; Brunicardi FC; Melchior F; Feng XH
J Biol Chem; 2003 May; 278(21):18714-9. PubMed ID: 12621041
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4.
Ohshima T; Shimotohno K
J Biol Chem; 2003 Dec; 278(51):50833-42. PubMed ID: 14514699
[TBL] [Abstract][Full Text] [Related]
4. Regulation of transforming growth factor-beta signaling by protein inhibitor of activated STAT, PIASy through Smad3.
Imoto S; Sugiyama K; Muromoto R; Sato N; Yamamoto T; Matsuda T
J Biol Chem; 2003 Sep; 278(36):34253-8. PubMed ID: 12815042
[TBL] [Abstract][Full Text] [Related]
5. Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4.
Chang CC; Lin DY; Fang HI; Chen RH; Shih HM
J Biol Chem; 2005 Mar; 280(11):10164-73. PubMed ID: 15637079
[TBL] [Abstract][Full Text] [Related]
6. Repression of Smad4 transcriptional activity by SUMO modification.
Long J; Wang G; He D; Liu F
Biochem J; 2004 Apr; 379(Pt 1):23-9. PubMed ID: 14750902
[TBL] [Abstract][Full Text] [Related]
7. Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT.
Long J; Matsuura I; He D; Wang G; Shuai K; Liu F
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9791-6. PubMed ID: 12904571
[TBL] [Abstract][Full Text] [Related]
8. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta receptor-associated protein 1 is a Smad4 chaperone.
Wurthner JU; Frank DB; Felici A; Green HM; Cao Z; Schneider MD; McNally JG; Lechleider RJ; Roberts AB
J Biol Chem; 2001 Jun; 276(22):19495-502. PubMed ID: 11278302
[TBL] [Abstract][Full Text] [Related]
10. SUMO Modification Reverses Inhibitory Effects of Smad Nuclear Interacting Protein-1 in TGF-β Responses.
Liu S; Long J; Yuan B; Zheng M; Xiao M; Xu J; Lin X; Feng XH
J Biol Chem; 2016 Nov; 291(47):24418-24430. PubMed ID: 27703003
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Smad4 sumoylation and transforming growth factor-beta signaling by protein inhibitor of activated STAT1.
Liang M; Melchior F; Feng XH; Lin X
J Biol Chem; 2004 May; 279(22):22857-65. PubMed ID: 15028714
[TBL] [Abstract][Full Text] [Related]
12. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation.
Zhu H; Kavsak P; Abdollah S; Wrana JL; Thomsen GH
Nature; 1999 Aug; 400(6745):687-93. PubMed ID: 10458166
[TBL] [Abstract][Full Text] [Related]
13. SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4.
Lin X; Liang M; Liang YY; Brunicardi FC; Feng XH
J Biol Chem; 2003 Aug; 278(33):31043-8. PubMed ID: 12813045
[TBL] [Abstract][Full Text] [Related]
14. Expression of functional Schistosoma mansoni Smad4: role in Erk-mediated transforming growth factor beta (TGF-beta) down-regulation.
Osman A; Niles EG; LoVerde PT
J Biol Chem; 2004 Feb; 279(8):6474-86. PubMed ID: 14630909
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
Zhang Y; Musci T; Derynck R
Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.
Kurisaki K; Kurisaki A; Valcourt U; Terentiev AA; Pardali K; Ten Dijke P; Heldin CH; Ericsson J; Moustakas A
Mol Cell Biol; 2003 Jul; 23(13):4494-510. PubMed ID: 12808092
[TBL] [Abstract][Full Text] [Related]
17. Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300.
Mori N; Morishita M; Tsukazaki T; Giam CZ; Kumatori A; Tanaka Y; Yamamoto N
Blood; 2001 Apr; 97(7):2137-44. PubMed ID: 11264182
[TBL] [Abstract][Full Text] [Related]
18. Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells.
Shimada K; Suzuki N; Ono Y; Tanaka K; Maeno M; Ito K
Bone; 2008 May; 42(5):886-93. PubMed ID: 18321803
[TBL] [Abstract][Full Text] [Related]
19. Loss of Smad4 function in pancreatic tumors: C-terminal truncation leads to decreased stability.
Maurice D; Pierreux CE; Howell M; Wilentz RE; Owen MJ; Hill CS
J Biol Chem; 2001 Nov; 276(46):43175-81. PubMed ID: 11553622
[TBL] [Abstract][Full Text] [Related]
20. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
